No Data
No Data
Trump's tariff plan is unpopular! More than half of the USA population opposes imposing taxes on commodities from Mexico.
①The plan of the USA's incoming president Trump to impose tariffs does not seem to be popular among the public. According to a poll, 51% of USA voters oppose imposing tariffs on commodities from Mexico, Canada, and China; ②Standard & Poor's states that USA tariffs will increase inflation rates and reduce economic output, while some citizens and businesses are stockpiling goods due to tariff concerns, leading to a significant increase in throughput at the ports of Los Angeles and Long Beach in November.
Goldman Sachs: Assigns HANSOH PHARMA a "Buy" rating with a Target Price of 20.97 HKD.
Goldman Sachs released a research report stating that HANSOH PHARMA (03692) announced on December 18 an exclusive Global licensing agreement with Merck for the oral GLP-1 small molecule drug HS-10535, with an initial payment of $0.112 billion and milestone payments of $1.9 billion, along with royalties based on product sales. Goldman Sachs believes that HANSOH PHARMA can promote or commercially develop this product jointly in the mainland and Hong Kong-Macau or separately. Goldman Sachs rated HANSOH PHARMA as "Buy" with a Target Price of HKD 20.97. The firm noted that this is HANSOH PHARMA's second collaboration with a multinational company in the past two years, following the previous cooperation with.
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Shares of Financial Companies Are Trading Lower Amid Overall Market Weakness Following the Fed's Rate Decision to Cut Rates by 25 Basis Points.
Express News | Shares of Financial Companies Are Trading Lower Amid Overall Market Weakness Following the Fed's Rate Decision to Cut Rates by 25 Basis Points
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year